As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow.
Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners.
It provides a 'how-to' for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements.
An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making.
- Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars
- Case studies are interspersed throughout each chapter to support key concepts and best practices.
- Enhanced by use of numerous detailed graphics, tables and flow charts
Section I: Biotechnology Entrepreneurship 1. Unleashing the Promise of Biotechnology to Help Heal, Fuel, and Feed the World 2. A Biotechnology Entrepreneur's Story: Advice to Future Entrepreneurs 3. The Biotechnology Industry: An Engine of Innovation 4. What is Biotechnology Entrepreneurship? 5. Five Essential Elements for Growing Biotechnology Clusters
Section II: The Human Capital 6. Characteristics of Successful Biotechnology Leaders 7. Building, Managing, and Motivating Great Teams 8. Building Human Relationship Networks
Section III: The Technology 9. Understanding Biotechnology Product Sectors 10. Technology Opportunities: Evaluating the Idea 11. Commercialization of Bioagricultural Products 12. Understanding Biotechnology Business Models and Managing Risk
Section IV: The Emerging-Stage Biotechnology Company 13. Company Formation, Ownership Structure, and Securities Issues 14. Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs 15. Intellectual Property Protection Strategies for Biotechnology Innovations
Section V: Biotechnology Market Development 16. Biotechnology Products and Their Customers: Developing a Successful Market Strategy 17. Biotechnology Product Coverage, Coding, and Reimbursement Strategies 18. Getting the Word Out: Using Public Relations Strategies to Support Biotechnology Business Goals
Section VI: The Financial Capital 19. Sources of Capital and Investor Motivations 20. Securing Angel Capital and Understanding How Angel Networks Operate 21. Understanding and Securing Venture Capital 22. Your Business Plan and Presentation: Articulating Your Journey to Commercialization
Section VII: Biotechnology Product Development 23. Therapeutic Drug Development and Human Clinical Trials 24. Development and Commercialization of In Vitro Diagnostics: Applications for Companion Diagnostics 25. Regulatory Approval and Compliances for Biotechnology Products 26. The Biomanufacturing of Biotechnology Products
Section VIII: The Later-Stage Biotechnology Company 27. Company Growth Stages and the Value of Corporate Culture 28. Biotechnology Business Development: The Art of the Deal 29. Biotech-Pharma Collaboration
A Strategic Tool: Case Study of Centocor 30. Ethical Considerations for Biotechnology Entrepreneurs 31. Career Opportunities in the Life Sciences Industry 32. Summary
Dr. Craig Shimasaki is a scientist, businessperson, and serial entrepreneur, with over 35 years of biotechnology industry experience starting his career at Genentech in South San Francisco, California. He cofounded nine life science companies and participated in taking five public in the US and Canadian stock exchanges. He is an inventor on multiple biotech patents and is currently the CEO of Moleculera Labs and BioSource Consulting. He teaches biotechnology entrepreneurship at the University of Oklahoma, United States, as an Entrepreneur-in-Residence at the Price School of Business. His passion is to train and equip entrepreneurial leaders to successfully translate basic discoveries into needed products and services for unmet medical needs.